adenosine monophosphate has been researched along with gemcitabine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Džubák, P; Gurská, S; Hajdúch, M; Hejtmánková, K; Hocek, M; Lišková, B; Oždian, T; Pohl, R; Smoleń, S; Tichý, M; Tloušt'ová, E | 1 |
Cai, WJ; Dong, YY; Liu, Y; Zhuang, YH; Zou, WB | 1 |
An, T; Jang, Y; Jung, E; Kim, K; Kim, M; Kim, UI; Lee, MK; Shin, JS | 1 |
3 other study(ies) available for adenosine monophosphate and gemcitabine
Article | Year |
---|---|
Synthesis and Cytostatic and Antiviral Profiling of Thieno-Fused 7-Deazapurine Ribonucleosides.
Topics: Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Hepacivirus; Hepatitis C; Humans; Neoplasms; Purines; Ribonucleosides | 2017 |
The mitochondrion interfering compound NPC-26 exerts potent anti-pancreatic cancer cell activity in vitro and in vivo.
Topics: Adenine Nucleotide Translocator 1; Adenosine Monophosphate; Adenosine Triphosphate; Adult; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cyclophilins; Deoxycytidine; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; In Vitro Techniques; Mice; Mice, Nude; Middle Aged; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Pancreatic Neoplasms; Peptidyl-Prolyl Isomerase F; Reactive Oxygen Species; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Deoxycytidine; Drug Therapy, Combination; Gemcitabine; Humans; Inhibitory Concentration 50; SARS-CoV-2; Vero Cells; Virus Replication | 2021 |